B. Riley Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$248 Buy
513
+42
+9% +$20.8K ﹤0.01% 592
2022
Q1
$231K Buy
+471
New +$215K 0.02% 522
2015
Q3
Sell
-400
Closed -$65K 306
2015
Q2
$65K Hold
400
0.05% 356
2015
Q1
$61K Sell
400
-175
-30% -$24.9K 0.05% 378
2014
Q4
$72K Sell
575
-100
-15% -$12.4K 0.06% 326
2014
Q3
$80K Sell
675
-100
-13% -$11.5K 0.06% 327
2014
Q2
$83K Sell
775
-100
-11% -$10.3K 0.05% 383
2014
Q1
$87K Buy
+875
New +$79.1K 0.06% 337

Other funds holding ELV

B. Riley Wealth Management's ELV Position: Q2 2022 in Review

B. Riley Wealth Management increased its Elevance Health (ELV) stake by 8.9% in Q2 2022, buying an estimated $20.8K and bringing the position to 513 shares worth $248. The position accounts for ﹤0.01% of the portfolio, ranked #592.

B. Riley Wealth Management first reported a position in ELV in Q1 2014 and has held it in 8 quarters since. The position peaked at $231K in Q1 2022. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • B. Riley Wealth Management held 513 shares of Elevance Health worth $248 as of Q2 2022.
  • B. Riley Wealth Management bought 42 Elevance Health shares in Q2 2022, an estimated $20.8K.
  • Elevance Health made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #592 holding.
  • B. Riley Wealth Management first reported a position in Elevance Health in Q1 2014 and has held it in 8 quarters since.
  • B. Riley Wealth Management's Elevance Health position peaked at $231K in Q1 2022.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.